Average Insider

Where insiders trade, we follow

Maze Therapeutics, Inc. ($MAZE)
Accession: 0001555132-26-000006
Jan 8, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$6.71
Current$48.0388.0% above low, 12.0% below high
52W High$53.65

Filing Information

Accession Number0001555132-26-000006
Form Type4
Filing DateJan 8, 2026
Document DateJan 6, 2026
DocumentView SEC Filing
Transactions
10
Total Shares
88,239
Total Value
$1,455,537.82

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Sohn Catherine A.
Director
Common Stock
โ€”Jan 6, 2026Exercise/Conversion2,493$10.42$25,977.062,493Directโ€”View Details
Sohn Catherine A.
Director
Common Stock
โ€”Jan 6, 2026Sale2,493$38.62$96,269.690Directโ€”View Details
Sohn Catherine A.
Director
Common Stock
โ€”Jan 7, 2026Exercise/Conversion20,744$10.42$216,152.4820,744Directโ€”View Details
Sohn Catherine A.
Director
Common Stock
โ€”Jan 7, 2026Exercise/Conversion2,895$10.42$30,165.9023,639Directโ€”View Details
Sohn Catherine A.
Director
Common Stock
โ€”Jan 7, 2026Exercise/Conversion3,281$10.42$34,188.0226,920Directโ€”View Details
Sohn Catherine A.
Director
Common Stock
โ€”Jan 7, 2026Sale26,920$39.11$1,052,784.670Directโ€”View Details
Sohn Catherine A.
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeJan 6, 2026Exercise/Conversion2,493$0.00$0.003,211Directโ€”View Details
Sohn Catherine A.
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeJan 7, 2026Exercise/Conversion20,744$0.00$0.000Directโ€”View Details
Sohn Catherine A.
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeJan 7, 2026Exercise/Conversion2,895$0.00$0.00316Directโ€”View Details
Sohn Catherine A.
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeJan 7, 2026Exercise/Conversion3,281$0.00$0.005,805Directโ€”View Details
Version: v26.3.23